Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.
NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.
Sieber Direct Communications At NCI, Reorganizing Offices.
“5 A Day” Review Underway to Check Program’s Health at NCI.
AACR Honors Nine Cancer Researchers, Clinicians.
Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.
FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.
Bristol-Myers, Karolinska In Collaboration For Studies.
Antigenics Begins Phase II Trial Of Oncophage for NHL.
Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS
RFP: Intellectual Property.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
- Survivorship begins at diagnosis—cancer care system must recognize this
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
